Evidence for protective immunity to Bancroftian filariasis in the Cook Islands

Journal of Infectious Diseases

Volumn 174, Issue 3, 1996, Pages 598-605

  Steel, Cathy ^a   Guinea, Archibald ^c   Ottesen, Eric A ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; FILARIASIS; HUMAN; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; WUCHERERIA BANCROFTI;

EID: 0029738089     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.3.598     Document Type: Article

References (28)

1. Ottesen EA, Weller PF, Heck L. Specific cellular immune unresponsiveness in human filariasis. Immunology 1977;33:413-21.
2. Weller PF, Ottesen EA, Heck L, Tere T, Neva FA. Endemic filariasis in the Pacific. I. Clinical, epidemiologic and parasitologic aspects. Am J Trop Med Hyg 1982;31:942-52.
3. Ottesen EA, Weller PF, Lunde M, Hussain R. Endemic filariasis in the Pacific. II. Immunologie aspects: immunoglobulin, complement and specific antifilarial IgG, IgM and IgE antibodies. Am J Trop Med Hyg 1982;31:953-61.
4. Freedman DO, Nutman TB, Ottesen EA. Protective immunity in human filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area. J Clin Invest 1989;83:14-22.
5. Ottesen EA. Filariasis now. Am J Trop Med Hyg 1989;41(suppl):9-17.
6. Day KP. The endemic normal in lymphatic filariasis: a static concept. Parasitol Today 1991;7:341-3.
7. Grenfell BT, Michael E. Infection and disease in lymphatic filariasis: an epidemiological approach. Parasitology 1992;104(suppl):S81-90.
8. Day KP, Gregory WF, Maizels RM. Age-specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea. Parasite Immunol 1991;13:277-90.
9. Day KP, Grenfell B, Spark R, Kazura JW, Alpers MP. Age-specific patterns of change in the dynamics of Wuchereria bancrofti infection in Papua New Guinea. Am J Trop Med Hyg 1991;44:518-27.
10. Weil GJ, Jain DC, Santhanam S, et al. A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis. J Infect Dis 1987;156:350-5.
11. Ottesen EA. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Rev Infect Dis 1985;7:341-56.
12. Dreyer G, Amaral F, Noroes J, Madeiros Z, Addiss D. A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for bancroftian filariasis. Trans R Soc Trop Med Hyg 1995;89:225-6.
13. Kaushal NA, Hussain R, Nash TE, Ottesen EA. Identification and characterization of excretory-secretory products of Brugia malayi adult filarial parasites. J Immunol 1982;129:338-43.
14. Lal RB, Ottesen EA. Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment. J Infect Dis 1988;158:1034-7.
15. King CL, Ottesen EA, Nutman TB. Cytokine regulation of antigen-driven IgE production in filarial parasite infections in humans. J Clin Invest 1990;85:1810-5.
16. Steel C, Guinea A, McCarthy JS, Ottesen EA. Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens. Lancet 1994;343:890-3.
17. Steel C, Lujan-Trangay A, Gonzalez-Peralta C, Zea Flores G, Nutman TB. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis. J Infect Dis 1994;170:962-70.
18. Denham DA, Ponnudurai T, Nelson GS, Rogers R, Guy F. Studies with Brugia pahangi. II. The effect of repeated infection on parasite levels in cats. Int J Parasitol 1972;2:401-7.
19. Grenfell BT, Michael E, Denham DA. A model for the dynamics of human lymphatic filariasis. Parasitol Today 1991;7:318-23.
20. Grieve RB, Abraham D, Mika-Grieve M, Seibert BP. Induction of protective immunity in dogs to infection with Dirofilaria immitis using chemically abbreviated infections. Am J Trop Med Hyg 1988;39:373-9.
21. Ash LR. Preferential susceptibility of male jirds (Meriones unguiculatus) to infection with Bnigia pahangi. J Parasitol 1971;57:777-80.
22. Philipp M, Davis TB, Storey N, Carlow CK. Immunity in filariasis: perspectives for vaccine development. Annu Rev Microbiol 1988;42:685-716.
23. Yazdanbakhsh M, Sartono E, Kruize YC, et al. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol 1993;23:3312-7.
24. Kazura JW, Hazlett FE Jr, Pearlman E, et al. Antigenicity of a protective recombinant filarial protein in human bancroftian filariasis. J Infect Dis 1992;166:1453-7.
25. Srividya A, Pani SP, Rajagopalan PK, Bundy DA, Grenfell BT. The dynamics of infection and disease in bancroftian filariasis. Trans R Soc Trop Med Hyg 1991;85:255-9.
26. Meyrowitsch DW, Simonsen PE, Makunde WH. A 16-year follow-up study on bancroftian filariasis in three communities of north-eastern Tanzania. Ann Trop Med Parasitol 1995;89:665-75.
27. Elson LH, Guderian RH, Araujo E, Bradley JE, Days A, Nutman TB. Immunity to onchocerciasis: putative immune individuals produce a Th1-like response to Onchocerca volvulus. J Infect Dis 1994;169:588-94.
28. Ottesen EA, Skvaril F, Tripathy SP, Poindexter RW, Hussain R. Prominence of IgG4 in the IgG antibody response to human filariasis. J Immunol 1985;134:2707-12.